Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy

被引:7
|
作者
Juan, Yun-Ting [1 ]
Chiang, Wen-Chih [2 ]
Lin, Wei-Chou [3 ]
Yang, Cheng-Wen [1 ]
Chou, San-Fang [4 ]
Hung, Ruo-Wei [1 ]
Chiu, Yen-Ling [1 ,4 ,5 ,6 ,7 ]
机构
[1] Far Eastern Mem Hosp, Dept Nephrol, New Taipei 220, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med, Div Nephrol, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
[4] Far Eastern Mem Hosp, Dept Med Res, New Taipei 220, Taiwan
[5] Yuan Ze Univ, Grad Inst Med, Taoyuan 320, Taiwan
[6] Yuan Ze Univ, Grad Program Biomed Informat, Taoyuan 320, Taiwan
[7] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 100, Taiwan
关键词
complement C5a; factor Ba; galactose-deficient IgA1; IgA nephropathy; Oxford classification;
D O I
10.3390/jcm11144231
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our prior study indicates a close relationship between alternative complement pathway activation, galactose-deficient IgA1 (Gd-IgA1) concentration and clinical severity of IgA nephropathy (IgAN). Nonetheless, the relationship between complement factors and the updated Oxford classification of IgAN remains unclear. This study enrolled eighty-four previously untreated, biopsy-diagnosed IgAN patients. The clinical and laboratory findings were collected at the time of biopsy. Plasma levels of complement factor C5a, factor Ba and Gd-IgA1 were measured and analyzed. It was found that the levels of proteinuria positively correlated with the updated Oxford classification of mesangial hypercellularity (M), endocapillary hypercellularity (E), tubular atrophy/interstitial fibrosis (T) and crescents (C). In addition, plasma Gd-IgA1 titer was significantly elevated in IgAN patients with tubular atrophy/interstitial fibrosis (T). In separate multivariable logistic regression models, both Gd-IgA1 and factor Ba independently predict higher T scores. The results indicate that both the levels of Gd-IgA1 antibody and biomarkers of the alternative complement pathway activation reflect the Oxford classification of IgAN. Whether these biomarkers can be used to guide therapeutic decisions requires further study.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Associations Between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody, and the Updated Oxford Pathology Classification of IgA Nephropathy
    Juan, Yunting
    Chiu, Yen-Ling
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 502 - 502
  • [2] Correlation of Serum Galactose-Deficient IgA1 and Oxford Class in Cases of IgA Nephropathy
    Shukla, Monika
    Malhotra, Kiran Preet
    Chandra, Abhilash
    Rao, Namrata Sarvepalli
    Ahmad, Mohammad Kaleem
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (11) : 1244 - 1250
  • [3] Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients
    Chiu, Yen-Ling
    Lin, Wei-Chou
    Shu, Kai-Hsiang
    Fang, Yi-Wen
    Chang, Fan-Chi
    Chou, Yu-Hsiang
    Wu, Ching-Fang
    Chiang, Wen-Chih
    Lin, Shuei-Liong
    Chen, Yung-Ming
    Wu, Ming-Shiou
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] GLOMERULAR GALACTOSE-DEFICIENT IGA1 IS SPECIFIC FOR IGA NEPHROPATHY
    Suzuki, Hitoshi
    Makita, Yuko
    Takagi, Miyuki
    Kano, Toshiki
    Nogi, Chieko
    Takahata, Akiko
    Suzuki, Yusuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 127 - 128
  • [5] Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy
    Mestecky, J
    Novak, J
    Julian, BA
    Tomana, M
    NEPHROLOGY, 2002, 7 : S92 - S99
  • [6] Serum galactose-deficient IgA1 levels in children with IgA nephropathy
    Jiang, Mengjie
    Jiang, Xiaoyun
    Rong, Liping
    Xu, Yuanyuan
    Chen, Lizhi
    Qiu, Zeting
    Mo, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7861 - 7866
  • [7] Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
    Fukao, Yusuke
    Suzuki, Hitoshi
    Kim, Jin Sug
    Jeong, Kyung Hwan
    Makita, Yuko
    Kano, Toshiki
    Nihei, Yoshihito
    Nakayama, Maiko
    Lee, Mingfeng
    Kato, Rina
    Chang, Jer-Ming
    Lee, Sang Ho
    Suzuki, Yusuke
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [8] Helicobacter pyloriinfection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
    Liu, Xing-Zi
    Zhang, Yue-Miao
    Jia, Ni-Ya
    Zhang, Hong
    RENAL FAILURE, 2020, 42 (01) : 539 - 546
  • [9] LIF SIGNALING ENHANCES PRODUCTION OF GALACTOSE-DEFICIENT IGA1 IN IGA NEPHROPATHY
    Yamada, Koshi
    Huang, Zhi-Qiang
    Raska, Milan
    Reily, Colin
    Anderson, Joshua
    Suzuki, Hitoshi
    Kiryluk, Krzysztof
    Gharavi, Ali
    Julian, Bruce
    Willey, Christopher
    Novak, Jan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [10] Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki, Hitoshi
    Allegri, Landino
    Suzuki, Yusuke
    Hall, Stacy
    Moldoveanu, Zina
    Wyatt, Robert J.
    Novak, Jan
    Julian, Bruce A.
    DISEASE MARKERS, 2016, 2016